Evidence map›Paper›PMID 23268600›Full record

ArticleMolecular pharmaceutics2013

Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures.

Amber Dahlin, Ethan Geier, Sophie L Stocker, Cheryl D Cropp, Elena Grigorenko, Michele Bloomer, Julie Siegenthaler, Lu Xu, Anthony S Basile, Diane D-S Tang-Liu and 1 more

Abstract read
In one paragraph

Article in Molecular pharmaceutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Biomicrofluidics · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Amber DahlinDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California 94158, United States.
Ethan Geier
Sophie L Stocker
Cheryl D Cropp
Elena Grigorenko
Michele Bloomer
Julie Siegenthaler
Lu Xu
Anthony S Basile
Diane D-S Tang-Liu
Kathleen M Giacomini
University of California, San Francisco · USAllergan (Ireland) · IEBoston Applied Technologies (United States) · US

Funding

Pharmacogenomics of Membrane TransportersU19GM061390 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WITTE, JOHN S. · 2010 to 2014
$16.3M
Genetic Epidemiology of Complex TraitsZIAHG200327 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BAILEY-WILSON, JOAN ELLEN · 2009 to 2022
$10.5M
PHARMACEUTICAL SCIENCES AND PHARMACOGENOMICST32GM007175 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AHITUV, NADAV, KROETZ, DEANNA L · 1985 to 2021
$7.1M
Training in Molecular& Genetic Epidemiology of CancerR25CA112355 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WITTE, JOHN S. · 2005 to 2018
$6.5M
NCI NIH HHS R25 CA112355NIGMS NIH HHS T32 GM007175NIGMS NIH HHS U19 GM061390NIGMS NIH HHS U19GM061390
6 · The paper itself

Abstract

The barrier epithelia of the cornea and retina control drug and nutrient access to various compartments of the human eye. While ocular transporters are likely to play a critical role in homeostasis and drug delivery, little is known about their expression, localization and function. In this study, the mRNA expression levels of 445 transporters, metabolic enzymes, transcription factors and nuclear receptors were profiled in five regions of the human eye: cornea, iris, ciliary body, choroid and retina. Through RNA expression profiling and immunohistochemistry, several transporters were identified as putative targets for drug transport in ocular tissues. Our analysis identified SLC22A7 (OAT2), a carrier for the antiviral drug acyclovir, in the corneal epithelium, in addition to ABCG2 (BCRP), an important xenobiotic efflux pump, in retinal nerve fibers and the retinal pigment epithelium. Collectively, our results provide an understanding of the transporters that serve to maintain ocular homeostasis and which may be potential targets for drug delivery to deep compartments of the eye.

Indexed as

AcyclovirATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily G, Member 2CorneaEyeGene Expression ProfilingHumansImmunohistochemistryIn Vitro TechniquesNeoplasm ProteinsOrganic Anion Transporters, ATP-DependentOrganic Anion Transporters, Sodium-IndependentReal-Time Polymerase Chain ReactionRetinaReverse Transcriptase Polymerase Chain ReactionABCG2 protein, humanAcyclovirATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily G, Member 2Neoplasm ProteinsOrganic Anion Transporters, ATP-DependentOrganic Anion Transporters, Sodium-IndependentSLC22A7 protein, human

Identifiers

PMID23268600
PMCPMC4032224
OpenAlexW2033459628

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.